Daxor Corp
DXR- Exchange
- Nasdaq
- SEC CIK
- 0000027367
No open-market purchases or sales by Daxor Corp insiders were filed in the last 90 days; 15 institutions reported holding it in 13F filings for Q2 2026, worth $4.33M in total; no superinvestor holds it.
13F holders, Q1 2026
Institutional positions in Daxor Corp as of Mar 31, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 15
- +7 vs. Q4 2025
- Shares held
- 420.1K
- +372.4K (+781.1%) vs. Q4 2025
- Total value
- $4.07M
- +$3.36M (+478.4%) vs. Q4 2025
- New holders
- 8
- 0 more added
- Sold out
- 1
- 3 more reduced
1 institution that held it in Q4 2025 haven't filed for Q1 2026 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting DXR on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 15 | $4.33M |
| Q1 2026 | 15 | $4.07M |
| Q4 2025 | 9 | $1.43M |
| Q3 2025 | 7 | $1.16M |
| Q2 2025 | 7 | $973.6K |
| Q1 2025 | 8 | $784.9K |
| Q4 2024 | 10 | $816.5K |
| Q3 2024 | 10 | $756.7K |
| Q2 2024 | 7 | $740.5K |
| Q1 2024 | 8 | $669.5K |
| Q4 2023 | 7 | $607.9K |
| Q3 2023 | 6 | $594.9K |
| Q2 2023 | 6 | $627.5K |
| Q1 2023 | 5 | $689.5K |
| Q4 2022 | 5 | $601.1K |
| Q3 2022 | 5 | $893.0K |
| Q2 2022 | 5 | $926.0K |
| Q1 2022 | 5 | $755.0K |
| Q4 2021 | 6 | $1.03M |
| Q3 2021 | 6 | $1.51M |
| Q2 2021 | 7 | $1.80M |
| Q1 2021 | 7 | $2.33M |
Institutions, Q1 2026
Shares, value and share of portfolio for each institution holding Daxor Corp; share changes are against Q4 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Wells Fargo & Company | 0 | $1 | 0.00% | 0 | Unchanged |
| JPMorgan Chase & Co | 1 | $10 | 0.00% | −4−80.0% | Reduced |
| Tower Research Capital LLC (TRC) | 109 | $1.05K | 0.00% | +109 | New |
| Advisor Group Holdings, Inc. | 500 | $4.83K | 0.00% | 00.0% | Unchanged |
| Vanguard Fiduciary Trust Co | 1,037 | $10.1K | 0.00% | +1,037 | New |
| Morgan Stanley | 3,087 | $29.9K | 0.00% | −150−4.6% | Reduced |
| SBI Securities Co., Ltd. | 3,128 | $30.2K | 0.00% | 00.0% | Unchanged |
| Crescent Grove Advisors, LLC | 10,723 | $103.7K | 0.01% | +10,723 | New |
| Nano Cap New Millennium Growth Fund L P | 12,500 | $121.5K | 0.11% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 13,720 | $133.4K | 0.00% | +13,720 | New |
| Empirical Financial Services, LLC d.b.a. Empirical Wealth Management | 25,192 | $244.9K | 0.00% | +25,192 | New |
| Renaissance Technologies LLC | 28,011 | $270.9K | 0.00% | −210−0.7% | Reduced |
| Aristides Capital LLC | 41,692 | $403.2K | 0.13% | +41,692 | New |
| Vanguard Capital Management LLC | 48,280 | $469.3K | 0.00% | +48,280 | New |
| Thompson Siegel & Walmsley LLC | 232,120 | $2.25M | 0.04% | +232,120 | New |
| UBS Group AG | 0 | $0 | 0.00% | −90−100.0% | Sold out |
| Vanguard Group Inc | – | – | – | – | Not filed |